Security Snapshot

VANGUARD INTL EQUITY INDEX F - FTSE EMR MKT ETF (VWO) Institutional Ownership

CUSIP: 922042858

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

2,453

Shares (Excl. Options)

1,400,321,738

Price

$53.76

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Type / Class
Equity / FTSE EMR MKT ETF
Symbol
VWO
Price per share
$54.05
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
1,400,321,738
Total reported value
$75,338,383,261
% of total 13F portfolios
0.2%
Share change
+45,230,129
Value change
+$2,435,027,717
Number of holders
2,453
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • VWO - VANGUARD INTL EQUITY INDEX F - FTSE EMR MKT ETF is tracked under CUSIP 922042858.
  • 2453 institutions reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 2,453 to 905 between Q4 2025 and Q1 2026.
  • Reported value moved from $75,338,383,261 to $7,621,163,371.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 2453 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 922042858?
CUSIP 922042858 identifies VWO - VANGUARD INTL EQUITY INDEX F - FTSE EMR MKT ETF in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 2,453 institutional investors reported holding 1,400,321,738 shares of VANGUARD INTL EQUITY INDEX F - FTSE EMR MKT ETF (VWO).

Institutional Holders of VANGUARD INTL EQUITY INDEX F - FTSE EMR MKT ETF (VWO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 140,720,593 $7,621,163,371 +$33,782,146 $54.05 905
2025 Q4 1,400,321,738 $75,338,383,261 +$2,435,027,717 $53.76 2,453
2025 Q3 1,343,231,102 $72,778,809,657 +$1,670,991,045 $54.18 2,281
2025 Q2 1,323,287,091 $65,462,051,408 +$1,359,909,936 $49.46 2,241
2025 Q1 1,298,223,040 $58,730,779,450 +$800,550,429 $45.26 2,189
2024 Q4 1,287,269,049 $56,676,706,333 +$3,442,435,525 $44.04 2,217
2024 Q3 1,207,223,360 $57,738,609,601 -$1,642,412,120 $47.85 2,074
2024 Q2 1,244,113,031 $54,433,586,307 +$731,147,534 $43.76 2,036
2024 Q1 1,226,083,928 $51,216,005,589 +$150,487,191 $41.77 2,020
2023 Q4 1,220,460,677 $50,148,851,119 +$645,316,804 $41.10 2,039
2023 Q3 1,196,630,126 $46,920,061,696 +$206,047,600 $39.21 1,903
2023 Q2 1,184,024,102 $48,177,123,877 -$1,261,628,983 $40.68 1,924
2023 Q1 1,200,913,165 $48,275,703,827 +$1,283,482,069 $40.40 1,896
2022 Q4 1,186,441,613 $46,304,888,391 +$1,605,421,961 $38.98 1,884
2022 Q3 1,140,741,800 $42,002,535,757 -$85,469,160 $36.49 1,765
2022 Q2 1,146,614,943 $47,775,103,415 +$241,497,060 $41.65 1,839
2022 Q1 1,143,384,934 $52,746,127,040 -$317,021,888 $46.13 1,884
2021 Q4 1,147,584,951 $56,770,961,780 +$2,289,941,218 $49.46 1,902
2021 Q3 1,077,179,365 $53,805,807,372 +$926,024,753 $50.01 1,684
2021 Q2 1,058,751,887 $57,483,109,033 +$2,093,964,540 $54.31 1,730
2021 Q1 1,024,739,791 $53,287,935,724 +$4,422,302,050 $52.05 1,711
2020 Q4 938,039,686 $47,020,355,905 +$883,522,017 $50.11 1,653
2020 Q3 885,550,225 $38,301,466,450 +$151,367,301 $43.24 1,475
2020 Q2 880,415,202 $34,910,752,056 -$1,676,690,234 $39.61 1,428
2020 Q1 924,502,030 $31,044,440,383 -$1,303,352,961 $33.55 1,428
2019 Q4 949,346,942 $42,199,579,388 -$21,888,069 $44.47 1,535
2019 Q3 943,502,628 $38,082,246,199 -$471,216,613 $40.26 1,379
2019 Q2 954,428,450 $40,588,607,335 -$394,763,064 $42.53 1,387
2019 Q1 964,863,408 $41,008,282,792 +$1,782,988,368 $42.50 1,391
2018 Q4 920,234,866 $35,073,890,504 +$249,197,280 $38.10 1,361
2018 Q3 902,344,275 $36,990,568,276 -$506,671,590 $41.00 1,258
2018 Q2 912,511,854 $38,512,452,813 +$966,404,810 $42.20 1,261
2018 Q1 912,151,410 $42,760,103,342 -$190,556,788 $46.98 1,306
2017 Q4 914,421,392 $41,996,685,994 +$355,040,152 $45.91 1,285
2017 Q3 892,001,712 $38,865,467,561 +$2,230,989,396 $43.57 1,116
2017 Q2 841,257,429 $34,345,553,132 +$2,160,024,410 $40.83 1,073
2017 Q1 787,686,777 $31,288,368,508 +$1,648,473,774 $39.72 1,054
2016 Q4 746,012,556 $26,707,050,258 +$2,017,569,019 $35.78 1,006
2016 Q3 677,013,397 $25,467,074,399 +$2,585,618,807 $37.63 927
2016 Q2 607,816,309 $21,413,441,886 +$770,079,860 $35.23 893
2016 Q1 587,739,064 $20,322,484,788 -$73,074,107 $34.58 884
2015 Q4 590,233,931 $19,293,669,251 -$257,621,086 $32.71 880
2015 Q3 591,986,717 $19,605,959,931 -$2,773,499,935 $33.09 820
2015 Q2 673,296,928 $27,530,771,008 -$223,465,188 $40.88 880
2015 Q1 680,656,014 $27,822,824,166 +$836,611,586 $40.87 878
2014 Q4 656,114,759 $26,257,291,101 +$266,993,176 $40.02 880
2014 Q3 639,907,579 $26,686,372,242 +$1,318,424,795 $41.71 822
2014 Q2 615,614,998 $26,550,770,051 +$469,606,533 $43.13 817
2014 Q1 604,558,288 $24,530,464,282 -$2,077,535,296 $40.58 781